A carregar...
Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain cancer. Since median overall survival with multimodal standard therapy is only 15 months, there is a clear need for additional effective and long-lasting treatments. Dendritic cell (DC) vaccination is an exper...
Na minha lista:
| Publicado no: | Immunotargets Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918234/ https://ncbi.nlm.nih.gov/pubmed/27471700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S40121 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|